Cargando…
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
BACKGROUND: Denosumab has been shown to reduce tumor size and progression, reform mineralized bone, and increase intralesional bone density in patients with giant cell tumor of bone (GCTB); however, radiologic assessment of tumors in bone is challenging. The study objective was to assess tumor respo...
Autores principales: | Engellau, Jacob, Seeger, Leanne, Grimer, Robert, Henshaw, Robert, Gelderblom, Hans, Choy, Edwin, Chawla, Sant, Reichardt, Peter, O’Neal, Michael, Feng, Amy, Jacobs, Ira, Roberts, Zachary J., Braun, Ada, Bach, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146657/ https://www.ncbi.nlm.nih.gov/pubmed/30231890 http://dx.doi.org/10.1186/s12957-018-1478-3 |
Ejemplares similares
-
Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum
por: Bukata, Susan V., et al.
Publicado: (2021) -
Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone
por: Rutkowski, Piotr, et al.
Publicado: (2015) -
Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015) -
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
por: Gaston, Czar Louie, et al.
Publicado: (2016) -
The dilemma of denosumab: Salvage of a femoral head giant cell tumour
por: Gaston, Czar Louie, et al.
Publicado: (2014)